Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates

Press/Media

Period	27 Dec 2018

Media coverage

Title	Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates
Media name/outlet	FirstWord Pharma
Country/Territory	United States
Date	27/12/18
URL	www.firstwordpharma.com/node/1614064?tsid=1
Persons	Jeremiah Faith